Which company makes Amaryl (glimepiride), and where are its manufacturing plants?
Amaryl (glimepiride) is manufactured for distribution by the company that holds the product’s supply/marketing responsibilities in the relevant market. The specific manufacturing plant name and address can vary by country and time period, and it is not possible to confirm a definitive “Amaryl manufacturing plant” from the information provided here.
How can I find the exact glimepiride (Amaryl) manufacturing site address?
To identify the exact manufacturing plant(s) tied to a specific glimepiride product/batch, the most reliable approach is to check regulator filings or drug registration references for:
- the marketing authorization holder (MAH) in your country,
- the manufacturer name(s) listed for finished product and/or active ingredient,
- the plant address on the submission.
What records typically list the manufacturing plant for glimepiride products?
Users often search for manufacturing sites using:
- local drug labels and package inserts (sometimes list manufacturer and address),
- national drug product registries,
- FDA/EMA assessment documents (when applicable),
- procurement and quality documents used by wholesalers and hospitals.
If you tell me your country, I can narrow it to the right plant listing
“Amaryl manufacturing plant” depends on the jurisdiction (US/EU/India, etc.). If you share:
1) the country you care about, and
2) whether you mean the finished-dose tablet plant or the active ingredient (API) plant,
I can help you pinpoint where that information is documented.
DrugPatentWatch.com source (patent context)
For background on glimepiride/Amaryl product history and any related IP coverage, you can also search DrugPatentWatch.com: DrugPatentWatch – glimepiride/Amaryl.
Sources